I Ranked Every Way to Lose Visceral Fat — Here's What Actually Works

Summary

Dr. Ashley Froese ranks strategies for reducing visceral fat, from supplements to prescription medications. She argues that effective approaches reduce long-term fat-storage signals while helping the body mobilize fat. She also connects visceral fat with inflammation, insulin resistance, and stress. The video is educational and is not a substitute for personal medical advice.

Strategies, ranked from least to most effective

1. Vitamins and supplements: The presenter says evidence is weak for most supplements discussed, including chromium, vitamins A and K, CLA, fish oil, and green tea. She notes some evidence for vitamin D3 in people with metabolic syndrome and for soluble fiber, which may increase fullness and reduce food intake.

2. Sleep and stress management: She recommends consistently getting around 7–8 hours of sleep. In the video’s account, too little sleep can affect cortisol and appetite-related hormones; sleeping more than eight hours was not described as providing additional benefit.

3. Exercise:

   • Weight training is encouraged for overall health and muscle challenge, though the presenter says it has the smallest effect on visceral fat among the exercise approaches compared.
   • Moderate continuous cardio: She suggests about 45 minutes, 5–6 days per week—roughly 300 minutes weekly—at an intensity where you can still talk.
   • HIIT: Presented as the strongest exercise option, with a suggested target of about 30 minutes, five days per week. The presenter cautions that excessive exercise, particularly beyond roughly 300 minutes weekly, may backfire.

4. Calorie reduction: The video says reducing intake by about 500 calories per day for at least 12 weeks may reduce visceral fat more than exercise alone. It cautions against overly aggressive restriction, which may increase stress without producing proportionally greater fat loss.

5. Prescription medications: These are presented as the most potent options, but they require medical guidance and are not appropriate for everyone.

   • Metformin: The presenter reports greater reductions in people with insulin resistance than in people without it.
   • SGLT2 inhibitors: Examples include empagliflozin, dapagliflozin, and canagliflozin. The video notes that these are diabetes drugs and warns about the risk of yeast infections.
   • Tesamorelin: Discussed as a drug approved for HIV-associated lipodystrophy, with the presenter also referring to studies in people without HIV.
   • GLP-1-based medications: The video reports the largest reductions with semaglutide and tirzepatide, and describes retatrutide as a promising drug still on the horizon. These medications should be discussed with a clinician.

Monitoring and overall takeaway

The presenter suggests assessing body composition with a DEXA scan or a home body-composition device. Blood tests she mentions include fasting glucose and insulin, A1C, hs-CRP, sex hormones, DHEA, and cortisol.

Her central recommendation is to manage chronic stress, support sleep, use appropriate exercise and calorie strategies, and consider medication only with a healthcare professional.

Presenter and sources mentioned: Dr. Ashley Froese (also rendered as “Frazey” in the auto-generated captions); clinical studies and trials, not individually named; DEXA scans; Hume BodyPod, the video’s sponsor.